Tyra Bioscience Poised for Growth: Buy Rating Affirmed Amid Promising Clinical Trials and Strategic Drug Development

1mon ago, source: Business Insider

Tyra Bioscience (TYRA) Company Description: Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for ...

Tyra Bioscience Secures $200M for Clinical Drug Development

2mon ago, source: TipRanks on MSN

Tyra Biosciences, Inc. has initiated a $200 million private placement by agreeing to sell over 9 million shares and ...

Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights

1mon ago, source: Stockhouse

March 19, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities ...

Tyra Biosciences Inc

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares

1mon ago, source: Yahoo Finance

Tyra Biosciences Inc (NASDAQ:TYRA), a company focused on developing precision medicine for patients with cancer, has reported an insider sell according to a recent SEC filing. Daniel Bensen, the Chief ...

Tyra Biosciences Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Tyra Biosciences Inc.

1mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...